Mark E. Scott

1.7k total citations
32 papers, 1.3k citations indexed

About

Mark E. Scott is a scholar working on Epidemiology, Immunology and Microbiology. According to data from OpenAlex, Mark E. Scott has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Immunology and 7 papers in Microbiology. Recurrent topics in Mark E. Scott's work include Cervical Cancer and HPV Research (14 papers), Reproductive System and Pregnancy (8 papers) and Reproductive tract infections research (7 papers). Mark E. Scott is often cited by papers focused on Cervical Cancer and HPV Research (14 papers), Reproductive System and Pregnancy (8 papers) and Reproductive tract infections research (7 papers). Mark E. Scott collaborates with scholars based in United States, Canada and Australia. Mark E. Scott's co-authors include Anna‐Barbara Moscicki, Yifei Ma, Mayumi Nakagawa, Sepideh Farhat, Daniel P. Stites, Ibrahim Daud, Stephen Shiboski, Stephen Shiboski, Joel M. Palefsky and Nancy K. Hills and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Mark E. Scott

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Scott United States 18 772 573 254 191 155 32 1.3k
Peggy A. Crowley‐Nowick United States 24 587 0.8× 773 1.3× 280 1.1× 155 0.8× 147 0.9× 40 1.5k
Judith F. Smith United States 16 1.0k 1.3× 366 0.6× 78 0.3× 330 1.7× 193 1.2× 18 1.4k
Sepideh Farhat United States 19 1.2k 1.5× 618 1.1× 232 0.9× 591 3.1× 136 0.9× 31 1.6k
Koen D. Quint Netherlands 22 869 1.1× 214 0.4× 284 1.1× 326 1.7× 152 1.0× 88 1.3k
Shelley Segal United Kingdom 16 359 0.5× 485 0.8× 123 0.5× 63 0.3× 159 1.0× 30 968
Sudha Salhan India 25 472 0.6× 432 0.8× 633 2.5× 203 1.1× 228 1.5× 83 1.5k
Alison Fiander United Kingdom 27 1.7k 2.2× 841 1.5× 172 0.7× 620 3.2× 352 2.3× 95 2.5k
Georg Stary Austria 27 464 0.6× 1.4k 2.5× 361 1.4× 236 1.2× 394 2.5× 79 2.5k
Keerti V. Shah United States 13 871 1.1× 209 0.4× 101 0.4× 404 2.1× 151 1.0× 16 1.2k
Jane Sterling United Kingdom 27 1.5k 2.0× 635 1.1× 118 0.5× 637 3.3× 412 2.7× 52 2.4k

Countries citing papers authored by Mark E. Scott

Since Specialization
Citations

This map shows the geographic impact of Mark E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Scott more than expected).

Fields of papers citing papers by Mark E. Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Scott. The network helps show where Mark E. Scott may publish in the future.

Co-authorship network of co-authors of Mark E. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Scott. A scholar is included among the top collaborators of Mark E. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Scott. Mark E. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Anne B., Keith Grimwood, Mark E. Scott, et al.. (2021). Medication and healthcare use, parent knowledge and cough in children: A cohort study. Pediatric Pulmonology. 56(7). 2345–2354. 3 indexed citations
2.
O’Grady, Kerry-Ann, Keith Grimwood, Paul J. Torzillo, et al.. (2019). Effectiveness of a chronic cough management algorithm at the transitional stage from acute to chronic cough in children: a multicenter, nested, single-blind, randomised controlled trial. The Lancet Child & Adolescent Health. 3(12). 889–898. 15 indexed citations
3.
Scott, Mark E., et al.. (2018). Toll‐like receptors: Important immune checkpoints in the regression of cervical intra‐epithelial neoplasia 2. International Journal of Cancer. 143(11). 2884–2891. 20 indexed citations
4.
Moscicki, Anna‐Barbara, Rupert Kaul, Yifei Ma, et al.. (2011). Measurement of Mucosal Biomarkers in a Phase 1 Trial of Intravaginal 3% StarPharma LTD 7013 Gel (VivaGel) to Assess Expanded Safety. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(2). 134–140. 50 indexed citations
5.
Hwang, Loris Y., Mark E. Scott, Yifei Ma, & Anna‐Barbara Moscicki. (2010). Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. Journal of Reproductive Immunology. 88(1). 66–71. 55 indexed citations
6.
Cohen, Craig R., Anna Barbara Moscicki, Mark E. Scott, et al.. (2010). Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS. 24(13). 2069–2074. 53 indexed citations
7.
Daud, Ibrahim, Mark E. Scott, Yifei Ma, et al.. (2010). Association between toll‐like receptor expression and human papillomavirus type 16 persistence. International Journal of Cancer. 128(4). 879–886. 133 indexed citations
8.
Daud, Ibrahim & Mark E. Scott. (2008). Validation of Reference Genes in Cervical Cell Samples from Human Papillomavirus-Infected and -Uninfected Women for Quantitative Reverse Transcription-PCR Assays. Clinical and Vaccine Immunology. 15(9). 1369–1373. 34 indexed citations
9.
Scott, Mark E., et al.. (2008). Diminished IFN‐γ and IL‐10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. International Journal of Cancer. 124(6). 1379–1383. 53 indexed citations
10.
Scott, Mark E., Yifei Ma, Sepideh Farhat, Stephen Shiboski, & Anna‐Barbara Moscicki. (2006). Covariates of Cervical Cytokine mRNA Expression by Real-Time PCR in Adolescents and Young Women: Effects of Chlamydia trachomatis Infection, Hormonal Contraception, and Smoking. Journal of Clinical Immunology. 26(3). 222–232. 44 indexed citations
11.
Chugh, Sanjay, Mark E. Scott, David Goodhart, et al.. (2004). Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention. Journal of the American College of Cardiology. 44(4). 778–782. 19 indexed citations
12.
Nakagawa, Mayumi, Daniel P. Stites, Sandeep Patel, et al.. (2000). Persistence of Human Papillomavirus Type 16 Infection Is Associated with Lack of Cytotoxic T Lymphocyte Response to the E6 Antigens. The Journal of Infectious Diseases. 182(2). 595–598. 131 indexed citations
13.
Scott, Mark E., Daniel P. Stites, & Anna‐Barbara Moscicki. (1999). Th1 Cytokine Patterns in Cervical Human Papillomavirus Infection. Clinical and Diagnostic Laboratory Immunology. 6(5). 751–755. 103 indexed citations
14.
Scott, Mark E., Marek Kubin, & Steve Kohl. (1997). High Level Interleukin-12 Production, but Diminished Interferon-γ Production, by Cord Blood Mononuclear Cells. Pediatric Research. 41(4). 547–553. 38 indexed citations
15.
Scott, Mark E., et al.. (1995). Decreased Levels of Complement Receptor 1 (CD35) on B Lymphocytes in Persons with HIV Infection. Clinical Immunology and Immunopathology. 75(1). 20–25. 12 indexed citations
16.
Shapira, Nadiv, et al.. (1994). Lunular hypertrophy and aortic valve disease. The Annals of Thoracic Surgery. 57(2). 305–310. 4 indexed citations
17.
Scott, Mark E., Alan Landay, Thomas F. Lint, & Gregory T. Spear. (1993). In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection. AIDS. 7(1). 37–42. 15 indexed citations
18.
Scott, Mark E., et al.. (1980). Comparison of propranolol and inderal L.A. in patients with angina.. PubMed. 49(1). 79–84. 1 indexed citations
19.
Scott, Mark E., et al.. (1978). Reliable prediction of coronary disease using treadmill exercise testing.. BMJ. 1(6118). 958–959. 8 indexed citations
20.
Izukawa, T, Mark E. Scott, Farukh A. Durrani, & C.A.F. Möes. (1973). Persistent left fifth aortic arch in man. Report of two cases.. Heart. 35(11). 1190–1195. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peggy A. Crowley‐Nowick Breakdown of academic impact, for papers by Judith F. Smith Breakdown of academic impact, for papers by Sepideh Farhat Breakdown of academic impact, for papers by Koen D. Quint Breakdown of academic impact, for papers by Shelley Segal Breakdown of academic impact, for papers by Sudha Salhan Breakdown of academic impact, for papers by Alison Fiander Breakdown of academic impact, for papers by Georg Stary Breakdown of academic impact, for papers by Keerti V. Shah Breakdown of academic impact, for papers by Jane Sterling
Rankless by CCL
2026